Sale of a US-based med-tech company


US-based investment bank that advises on the full range of strategic transactions, including mergers, private placements, sell-side advisory and buy-side advisory

Business situation

  • Our client won a mandate to support a dual path process (capital raise and sale) of a company in the medical sterilization space
  • The company intended to explore strategic alternatives to accelerate its growth and fully realize the potential of its breakthrough sterilization technology through partnerships and fund raisings and eventually sell the company

SGA support

  • Prepared a detailed deck focusing on the USD8 billion sterilization market, powerful IP portfolio of 35 patents, existing contracts with big pharma and biotech companies, business model, high margin business and future cash flows
  • Identified deal opportunities and serial investors
  • Support across the deal life cycle which included:

  1. Buyer/Investor search and subsequent contacting
  2. Company Valuation
  3. Virtual Data Room management (including vendor negotiation)